Global Axillary Hyperhidrosis Drug Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Axillary Hyperhidrosis Drug will have significant change from previous year. According to our (LP Information) latest study, the global Axillary Hyperhidrosis Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Axillary Hyperhidrosis Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Axillary Hyperhidrosis Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Axillary Hyperhidrosis Drug market, reaching US$ million by the year 2028. As for the Europe Axillary Hyperhidrosis Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Axillary Hyperhidrosis Drug players cover Allergan Plc, Brickell Biotech Inc, Dermira Inc, and Dr. August Wolff GmbH & Co KG Arzneimittle, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Axillary Hyperhidrosis Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Axillary Hyperhidrosis Drug will have significant change from previous year. According to our (LP Information) latest study, the global Axillary Hyperhidrosis Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Axillary Hyperhidrosis Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Axillary Hyperhidrosis Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Axillary Hyperhidrosis Drug market, reaching US$ million by the year 2028. As for the Europe Axillary Hyperhidrosis Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Axillary Hyperhidrosis Drug players cover Allergan Plc, Brickell Biotech Inc, Dermira Inc, and Dr. August Wolff GmbH & Co KG Arzneimittle, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Axillary Hyperhidrosis Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Botulinum ToxinA
- Glycopyrrolate
- Glycopyrronium Tosylate
- Others
- Clinic
- Hospital
- Home Care
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Allergan Plc
- Brickell Biotech Inc
- Dermira Inc
- Dr. August Wolff GmbH & Co KG Arzneimittle
- GlaxoSmithKline Plc
- TheraVida Inc
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Axillary Hyperhidrosis Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Axillary Hyperhidrosis Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Axillary Hyperhidrosis Drug by Country/Region, 2017, 2022 & 2028
2.2 Axillary Hyperhidrosis Drug Segment by Type
2.2.1 Botulinum ToxinA
2.2.2 Glycopyrrolate
2.2.3 Glycopyrronium Tosylate
2.2.4 Others
2.3 Axillary Hyperhidrosis Drug Sales by Type
2.3.1 Global Axillary Hyperhidrosis Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Axillary Hyperhidrosis Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Axillary Hyperhidrosis Drug Sale Price by Type (2017-2022)
2.4 Axillary Hyperhidrosis Drug Segment by Application
2.4.1 Clinic
2.4.2 Hospital
2.4.3 Home Care
2.5 Axillary Hyperhidrosis Drug Sales by Application
2.5.1 Global Axillary Hyperhidrosis Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Axillary Hyperhidrosis Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Axillary Hyperhidrosis Drug Sale Price by Application (2017-2022)
3 GLOBAL AXILLARY HYPERHIDROSIS DRUG BY COMPANY
3.1 Global Axillary Hyperhidrosis Drug Breakdown Data by Company
3.1.1 Global Axillary Hyperhidrosis Drug Annual Sales by Company (2020-2022)
3.1.2 Global Axillary Hyperhidrosis Drug Sales Market Share by Company (2020-2022)
3.2 Global Axillary Hyperhidrosis Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Axillary Hyperhidrosis Drug Revenue by Company (2020-2022)
3.2.2 Global Axillary Hyperhidrosis Drug Revenue Market Share by Company (2020-2022)
3.3 Global Axillary Hyperhidrosis Drug Sale Price by Company
3.4 Key Manufacturers Axillary Hyperhidrosis Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Axillary Hyperhidrosis Drug Product Location Distribution
3.4.2 Players Axillary Hyperhidrosis Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR AXILLARY HYPERHIDROSIS DRUG BY GEOGRAPHIC REGION
4.1 World Historic Axillary Hyperhidrosis Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Axillary Hyperhidrosis Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Axillary Hyperhidrosis Drug Annual Revenue by Geographic Region
4.2 World Historic Axillary Hyperhidrosis Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Axillary Hyperhidrosis Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Axillary Hyperhidrosis Drug Annual Revenue by Country/Region
4.3 Americas Axillary Hyperhidrosis Drug Sales Growth
4.4 APAC Axillary Hyperhidrosis Drug Sales Growth
4.5 Europe Axillary Hyperhidrosis Drug Sales Growth
4.6 Middle East & Africa Axillary Hyperhidrosis Drug Sales Growth
5 AMERICAS
5.1 Americas Axillary Hyperhidrosis Drug Sales by Country
5.1.1 Americas Axillary Hyperhidrosis Drug Sales by Country (2017-2022)
5.1.2 Americas Axillary Hyperhidrosis Drug Revenue by Country (2017-2022)
5.2 Americas Axillary Hyperhidrosis Drug Sales by Type
5.3 Americas Axillary Hyperhidrosis Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Axillary Hyperhidrosis Drug Sales by Region
6.1.1 APAC Axillary Hyperhidrosis Drug Sales by Region (2017-2022)
6.1.2 APAC Axillary Hyperhidrosis Drug Revenue by Region (2017-2022)
6.2 APAC Axillary Hyperhidrosis Drug Sales by Type
6.3 APAC Axillary Hyperhidrosis Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Axillary Hyperhidrosis Drug by Country
7.1.1 Europe Axillary Hyperhidrosis Drug Sales by Country (2017-2022)
7.1.2 Europe Axillary Hyperhidrosis Drug Revenue by Country (2017-2022)
7.2 Europe Axillary Hyperhidrosis Drug Sales by Type
7.3 Europe Axillary Hyperhidrosis Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Axillary Hyperhidrosis Drug by Country
8.1.1 Middle East & Africa Axillary Hyperhidrosis Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Axillary Hyperhidrosis Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Axillary Hyperhidrosis Drug Sales by Type
8.3 Middle East & Africa Axillary Hyperhidrosis Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Axillary Hyperhidrosis Drug
10.3 Manufacturing Process Analysis of Axillary Hyperhidrosis Drug
10.4 Industry Chain Structure of Axillary Hyperhidrosis Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Axillary Hyperhidrosis Drug Distributors
11.3 Axillary Hyperhidrosis Drug Customer
12 WORLD FORECAST REVIEW FOR AXILLARY HYPERHIDROSIS DRUG BY GEOGRAPHIC REGION
12.1 Global Axillary Hyperhidrosis Drug Market Size Forecast by Region
12.1.1 Global Axillary Hyperhidrosis Drug Forecast by Region (2023-2028)
12.1.2 Global Axillary Hyperhidrosis Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Axillary Hyperhidrosis Drug Forecast by Type
12.7 Global Axillary Hyperhidrosis Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Allergan Plc
13.1.1 Allergan Plc Company Information
13.1.2 Allergan Plc Axillary Hyperhidrosis Drug Product Offered
13.1.3 Allergan Plc Axillary Hyperhidrosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Allergan Plc Main Business Overview
13.1.5 Allergan Plc Latest Developments
13.2 Brickell Biotech Inc
13.2.1 Brickell Biotech Inc Company Information
13.2.2 Brickell Biotech Inc Axillary Hyperhidrosis Drug Product Offered
13.2.3 Brickell Biotech Inc Axillary Hyperhidrosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Brickell Biotech Inc Main Business Overview
13.2.5 Brickell Biotech Inc Latest Developments
13.3 Dermira Inc
13.3.1 Dermira Inc Company Information
13.3.2 Dermira Inc Axillary Hyperhidrosis Drug Product Offered
13.3.3 Dermira Inc Axillary Hyperhidrosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Dermira Inc Main Business Overview
13.3.5 Dermira Inc Latest Developments
13.4 Dr. August Wolff GmbH & Co KG Arzneimittle
13.4.1 Dr. August Wolff GmbH & Co KG Arzneimittle Company Information
13.4.2 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Product Offered
13.4.3 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Dr. August Wolff GmbH & Co KG Arzneimittle Main Business Overview
13.4.5 Dr. August Wolff GmbH & Co KG Arzneimittle Latest Developments
13.5 GlaxoSmithKline Plc
13.5.1 GlaxoSmithKline Plc Company Information
13.5.2 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Product Offered
13.5.3 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 GlaxoSmithKline Plc Main Business Overview
13.5.5 GlaxoSmithKline Plc Latest Developments
13.6 TheraVida Inc
13.6.1 TheraVida Inc Company Information
13.6.2 TheraVida Inc Axillary Hyperhidrosis Drug Product Offered
13.6.3 TheraVida Inc Axillary Hyperhidrosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 TheraVida Inc Main Business Overview
13.6.5 TheraVida Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Axillary Hyperhidrosis Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Axillary Hyperhidrosis Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Axillary Hyperhidrosis Drug by Country/Region, 2017, 2022 & 2028
2.2 Axillary Hyperhidrosis Drug Segment by Type
2.2.1 Botulinum ToxinA
2.2.2 Glycopyrrolate
2.2.3 Glycopyrronium Tosylate
2.2.4 Others
2.3 Axillary Hyperhidrosis Drug Sales by Type
2.3.1 Global Axillary Hyperhidrosis Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Axillary Hyperhidrosis Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Axillary Hyperhidrosis Drug Sale Price by Type (2017-2022)
2.4 Axillary Hyperhidrosis Drug Segment by Application
2.4.1 Clinic
2.4.2 Hospital
2.4.3 Home Care
2.5 Axillary Hyperhidrosis Drug Sales by Application
2.5.1 Global Axillary Hyperhidrosis Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Axillary Hyperhidrosis Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Axillary Hyperhidrosis Drug Sale Price by Application (2017-2022)
3 GLOBAL AXILLARY HYPERHIDROSIS DRUG BY COMPANY
3.1 Global Axillary Hyperhidrosis Drug Breakdown Data by Company
3.1.1 Global Axillary Hyperhidrosis Drug Annual Sales by Company (2020-2022)
3.1.2 Global Axillary Hyperhidrosis Drug Sales Market Share by Company (2020-2022)
3.2 Global Axillary Hyperhidrosis Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Axillary Hyperhidrosis Drug Revenue by Company (2020-2022)
3.2.2 Global Axillary Hyperhidrosis Drug Revenue Market Share by Company (2020-2022)
3.3 Global Axillary Hyperhidrosis Drug Sale Price by Company
3.4 Key Manufacturers Axillary Hyperhidrosis Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Axillary Hyperhidrosis Drug Product Location Distribution
3.4.2 Players Axillary Hyperhidrosis Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR AXILLARY HYPERHIDROSIS DRUG BY GEOGRAPHIC REGION
4.1 World Historic Axillary Hyperhidrosis Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Axillary Hyperhidrosis Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Axillary Hyperhidrosis Drug Annual Revenue by Geographic Region
4.2 World Historic Axillary Hyperhidrosis Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Axillary Hyperhidrosis Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Axillary Hyperhidrosis Drug Annual Revenue by Country/Region
4.3 Americas Axillary Hyperhidrosis Drug Sales Growth
4.4 APAC Axillary Hyperhidrosis Drug Sales Growth
4.5 Europe Axillary Hyperhidrosis Drug Sales Growth
4.6 Middle East & Africa Axillary Hyperhidrosis Drug Sales Growth
5 AMERICAS
5.1 Americas Axillary Hyperhidrosis Drug Sales by Country
5.1.1 Americas Axillary Hyperhidrosis Drug Sales by Country (2017-2022)
5.1.2 Americas Axillary Hyperhidrosis Drug Revenue by Country (2017-2022)
5.2 Americas Axillary Hyperhidrosis Drug Sales by Type
5.3 Americas Axillary Hyperhidrosis Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Axillary Hyperhidrosis Drug Sales by Region
6.1.1 APAC Axillary Hyperhidrosis Drug Sales by Region (2017-2022)
6.1.2 APAC Axillary Hyperhidrosis Drug Revenue by Region (2017-2022)
6.2 APAC Axillary Hyperhidrosis Drug Sales by Type
6.3 APAC Axillary Hyperhidrosis Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Axillary Hyperhidrosis Drug by Country
7.1.1 Europe Axillary Hyperhidrosis Drug Sales by Country (2017-2022)
7.1.2 Europe Axillary Hyperhidrosis Drug Revenue by Country (2017-2022)
7.2 Europe Axillary Hyperhidrosis Drug Sales by Type
7.3 Europe Axillary Hyperhidrosis Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Axillary Hyperhidrosis Drug by Country
8.1.1 Middle East & Africa Axillary Hyperhidrosis Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Axillary Hyperhidrosis Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Axillary Hyperhidrosis Drug Sales by Type
8.3 Middle East & Africa Axillary Hyperhidrosis Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Axillary Hyperhidrosis Drug
10.3 Manufacturing Process Analysis of Axillary Hyperhidrosis Drug
10.4 Industry Chain Structure of Axillary Hyperhidrosis Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Axillary Hyperhidrosis Drug Distributors
11.3 Axillary Hyperhidrosis Drug Customer
12 WORLD FORECAST REVIEW FOR AXILLARY HYPERHIDROSIS DRUG BY GEOGRAPHIC REGION
12.1 Global Axillary Hyperhidrosis Drug Market Size Forecast by Region
12.1.1 Global Axillary Hyperhidrosis Drug Forecast by Region (2023-2028)
12.1.2 Global Axillary Hyperhidrosis Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Axillary Hyperhidrosis Drug Forecast by Type
12.7 Global Axillary Hyperhidrosis Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Allergan Plc
13.1.1 Allergan Plc Company Information
13.1.2 Allergan Plc Axillary Hyperhidrosis Drug Product Offered
13.1.3 Allergan Plc Axillary Hyperhidrosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Allergan Plc Main Business Overview
13.1.5 Allergan Plc Latest Developments
13.2 Brickell Biotech Inc
13.2.1 Brickell Biotech Inc Company Information
13.2.2 Brickell Biotech Inc Axillary Hyperhidrosis Drug Product Offered
13.2.3 Brickell Biotech Inc Axillary Hyperhidrosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Brickell Biotech Inc Main Business Overview
13.2.5 Brickell Biotech Inc Latest Developments
13.3 Dermira Inc
13.3.1 Dermira Inc Company Information
13.3.2 Dermira Inc Axillary Hyperhidrosis Drug Product Offered
13.3.3 Dermira Inc Axillary Hyperhidrosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Dermira Inc Main Business Overview
13.3.5 Dermira Inc Latest Developments
13.4 Dr. August Wolff GmbH & Co KG Arzneimittle
13.4.1 Dr. August Wolff GmbH & Co KG Arzneimittle Company Information
13.4.2 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Product Offered
13.4.3 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Dr. August Wolff GmbH & Co KG Arzneimittle Main Business Overview
13.4.5 Dr. August Wolff GmbH & Co KG Arzneimittle Latest Developments
13.5 GlaxoSmithKline Plc
13.5.1 GlaxoSmithKline Plc Company Information
13.5.2 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Product Offered
13.5.3 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 GlaxoSmithKline Plc Main Business Overview
13.5.5 GlaxoSmithKline Plc Latest Developments
13.6 TheraVida Inc
13.6.1 TheraVida Inc Company Information
13.6.2 TheraVida Inc Axillary Hyperhidrosis Drug Product Offered
13.6.3 TheraVida Inc Axillary Hyperhidrosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 TheraVida Inc Main Business Overview
13.6.5 TheraVida Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Axillary Hyperhidrosis Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Axillary Hyperhidrosis Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Botulinum ToxinA
Table 4. Major Players of Glycopyrrolate
Table 5. Major Players of Glycopyrronium Tosylate
Table 6. Major Players of Others
Table 7. Global Axillary Hyperhidrosis Drug Sales by Type (2017-2022) & (K Pcs)
Table 8. Global Axillary Hyperhidrosis Drug Sales Market Share by Type (2017-2022)
Table 9. Global Axillary Hyperhidrosis Drug Revenue by Type (2017-2022) & ($ million)
Table 10. Global Axillary Hyperhidrosis Drug Revenue Market Share by Type (2017-2022)
Table 11. Global Axillary Hyperhidrosis Drug Sale Price by Type (2017-2022) & (USD/Pcs)
Table 12. Global Axillary Hyperhidrosis Drug Sales by Application (2017-2022) & (K Pcs)
Table 13. Global Axillary Hyperhidrosis Drug Sales Market Share by Application (2017-2022)
Table 14. Global Axillary Hyperhidrosis Drug Revenue by Application (2017-2022)
Table 15. Global Axillary Hyperhidrosis Drug Revenue Market Share by Application (2017-2022)
Table 16. Global Axillary Hyperhidrosis Drug Sale Price by Application (2017-2022) & (USD/Pcs)
Table 17. Global Axillary Hyperhidrosis Drug Sales by Company (2020-2022) & (K Pcs)
Table 18. Global Axillary Hyperhidrosis Drug Sales Market Share by Company (2020-2022)
Table 19. Global Axillary Hyperhidrosis Drug Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Axillary Hyperhidrosis Drug Revenue Market Share by Company (2020-2022)
Table 21. Global Axillary Hyperhidrosis Drug Sale Price by Company (2020-2022) & (USD/Pcs)
Table 22. Key Manufacturers Axillary Hyperhidrosis Drug Producing Area Distribution and Sales Area
Table 23. Players Axillary Hyperhidrosis Drug Products Offered
Table 24. Axillary Hyperhidrosis Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Axillary Hyperhidrosis Drug Sales by Geographic Region (2017-2022) & (K Pcs)
Table 28. Global Axillary Hyperhidrosis Drug Sales Market Share Geographic Region (2017-2022)
Table 29. Global Axillary Hyperhidrosis Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Axillary Hyperhidrosis Drug Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Axillary Hyperhidrosis Drug Sales by Country/Region (2017-2022) & (K Pcs)
Table 32. Global Axillary Hyperhidrosis Drug Sales Market Share by Country/Region (2017-2022)
Table 33. Global Axillary Hyperhidrosis Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Axillary Hyperhidrosis Drug Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Axillary Hyperhidrosis Drug Sales by Country (2017-2022) & (K Pcs)
Table 36. Americas Axillary Hyperhidrosis Drug Sales Market Share by Country (2017-2022)
Table 37. Americas Axillary Hyperhidrosis Drug Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Axillary Hyperhidrosis Drug Revenue Market Share by Country (2017-2022)
Table 39. Americas Axillary Hyperhidrosis Drug Sales by Type (2017-2022) & (K Pcs)
Table 40. Americas Axillary Hyperhidrosis Drug Sales Market Share by Type (2017-2022)
Table 41. Americas Axillary Hyperhidrosis Drug Sales by Application (2017-2022) & (K Pcs)
Table 42. Americas Axillary Hyperhidrosis Drug Sales Market Share by Application (2017-2022)
Table 43. APAC Axillary Hyperhidrosis Drug Sales by Region (2017-2022) & (K Pcs)
Table 44. APAC Axillary Hyperhidrosis Drug Sales Market Share by Region (2017-2022)
Table 45. APAC Axillary Hyperhidrosis Drug Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Axillary Hyperhidrosis Drug Revenue Market Share by Region (2017-2022)
Table 47. APAC Axillary Hyperhidrosis Drug Sales by Type (2017-2022) & (K Pcs)
Table 48. APAC Axillary Hyperhidrosis Drug Sales Market Share by Type (2017-2022)
Table 49. APAC Axillary Hyperhidrosis Drug Sales by Application (2017-2022) & (K Pcs)
Table 50. APAC Axillary Hyperhidrosis Drug Sales Market Share by Application (2017-2022)
Table 51. Europe Axillary Hyperhidrosis Drug Sales by Country (2017-2022) & (K Pcs)
Table 52. Europe Axillary Hyperhidrosis Drug Sales Market Share by Country (2017-2022)
Table 53. Europe Axillary Hyperhidrosis Drug Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Axillary Hyperhidrosis Drug Revenue Market Share by Country (2017-2022)
Table 55. Europe Axillary Hyperhidrosis Drug Sales by Type (2017-2022) & (K Pcs)
Table 56. Europe Axillary Hyperhidrosis Drug Sales Market Share by Type (2017-2022)
Table 57. Europe Axillary Hyperhidrosis Drug Sales by Application (2017-2022) & (K Pcs)
Table 58. Europe Axillary Hyperhidrosis Drug Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Axillary Hyperhidrosis Drug Sales by Country (2017-2022) & (K Pcs)
Table 60. Middle East & Africa Axillary Hyperhidrosis Drug Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Axillary Hyperhidrosis Drug Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Axillary Hyperhidrosis Drug Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Axillary Hyperhidrosis Drug Sales by Type (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Axillary Hyperhidrosis Drug Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Axillary Hyperhidrosis Drug Sales by Application (2017-2022) & (K Pcs)
Table 66. Middle East & Africa Axillary Hyperhidrosis Drug Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Axillary Hyperhidrosis Drug
Table 68. Key Market Challenges & Risks of Axillary Hyperhidrosis Drug
Table 69. Key Industry Trends of Axillary Hyperhidrosis Drug
Table 70. Axillary Hyperhidrosis Drug Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Axillary Hyperhidrosis Drug Distributors List
Table 73. Axillary Hyperhidrosis Drug Customer List
Table 74. Global Axillary Hyperhidrosis Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 75. Global Axillary Hyperhidrosis Drug Sales Market Forecast by Region
Table 76. Global Axillary Hyperhidrosis Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Axillary Hyperhidrosis Drug Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Axillary Hyperhidrosis Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 79. Americas Axillary Hyperhidrosis Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Axillary Hyperhidrosis Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 81. APAC Axillary Hyperhidrosis Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Axillary Hyperhidrosis Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Europe Axillary Hyperhidrosis Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Axillary Hyperhidrosis Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Middle East & Africa Axillary Hyperhidrosis Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Axillary Hyperhidrosis Drug Sales Forecast by Type (2023-2028) & (K Pcs)
Table 87. Global Axillary Hyperhidrosis Drug Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Axillary Hyperhidrosis Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Axillary Hyperhidrosis Drug Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Axillary Hyperhidrosis Drug Sales Forecast by Application (2023-2028) & (K Pcs)
Table 91. Global Axillary Hyperhidrosis Drug Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Axillary Hyperhidrosis Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Axillary Hyperhidrosis Drug Revenue Market Share Forecast by Application (2023-2028)
Table 94. Allergan Plc Basic Information, Axillary Hyperhidrosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Allergan Plc Axillary Hyperhidrosis Drug Product Offered
Table 96. Allergan Plc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 97. Allergan Plc Main Business
Table 98. Allergan Plc Latest Developments
Table 99. Brickell Biotech Inc Basic Information, Axillary Hyperhidrosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Brickell Biotech Inc Axillary Hyperhidrosis Drug Product Offered
Table 101. Brickell Biotech Inc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 102. Brickell Biotech Inc Main Business
Table 103. Brickell Biotech Inc Latest Developments
Table 104. Dermira Inc Basic Information, Axillary Hyperhidrosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Dermira Inc Axillary Hyperhidrosis Drug Product Offered
Table 106. Dermira Inc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 107. Dermira Inc Main Business
Table 108. Dermira Inc Latest Developments
Table 109. Dr. August Wolff GmbH & Co KG Arzneimittle Basic Information, Axillary Hyperhidrosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Product Offered
Table 111. Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 112. Dr. August Wolff GmbH & Co KG Arzneimittle Main Business
Table 113. Dr. August Wolff GmbH & Co KG Arzneimittle Latest Developments
Table 114. GlaxoSmithKline Plc Basic Information, Axillary Hyperhidrosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Product Offered
Table 116. GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 117. GlaxoSmithKline Plc Main Business
Table 118. GlaxoSmithKline Plc Latest Developments
Table 119. TheraVida Inc Basic Information, Axillary Hyperhidrosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. TheraVida Inc Axillary Hyperhidrosis Drug Product Offered
Table 121. TheraVida Inc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 122. TheraVida Inc Main Business
Table 123. TheraVida Inc Latest Developments
Table 1. Axillary Hyperhidrosis Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Axillary Hyperhidrosis Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Botulinum ToxinA
Table 4. Major Players of Glycopyrrolate
Table 5. Major Players of Glycopyrronium Tosylate
Table 6. Major Players of Others
Table 7. Global Axillary Hyperhidrosis Drug Sales by Type (2017-2022) & (K Pcs)
Table 8. Global Axillary Hyperhidrosis Drug Sales Market Share by Type (2017-2022)
Table 9. Global Axillary Hyperhidrosis Drug Revenue by Type (2017-2022) & ($ million)
Table 10. Global Axillary Hyperhidrosis Drug Revenue Market Share by Type (2017-2022)
Table 11. Global Axillary Hyperhidrosis Drug Sale Price by Type (2017-2022) & (USD/Pcs)
Table 12. Global Axillary Hyperhidrosis Drug Sales by Application (2017-2022) & (K Pcs)
Table 13. Global Axillary Hyperhidrosis Drug Sales Market Share by Application (2017-2022)
Table 14. Global Axillary Hyperhidrosis Drug Revenue by Application (2017-2022)
Table 15. Global Axillary Hyperhidrosis Drug Revenue Market Share by Application (2017-2022)
Table 16. Global Axillary Hyperhidrosis Drug Sale Price by Application (2017-2022) & (USD/Pcs)
Table 17. Global Axillary Hyperhidrosis Drug Sales by Company (2020-2022) & (K Pcs)
Table 18. Global Axillary Hyperhidrosis Drug Sales Market Share by Company (2020-2022)
Table 19. Global Axillary Hyperhidrosis Drug Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Axillary Hyperhidrosis Drug Revenue Market Share by Company (2020-2022)
Table 21. Global Axillary Hyperhidrosis Drug Sale Price by Company (2020-2022) & (USD/Pcs)
Table 22. Key Manufacturers Axillary Hyperhidrosis Drug Producing Area Distribution and Sales Area
Table 23. Players Axillary Hyperhidrosis Drug Products Offered
Table 24. Axillary Hyperhidrosis Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Axillary Hyperhidrosis Drug Sales by Geographic Region (2017-2022) & (K Pcs)
Table 28. Global Axillary Hyperhidrosis Drug Sales Market Share Geographic Region (2017-2022)
Table 29. Global Axillary Hyperhidrosis Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Axillary Hyperhidrosis Drug Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Axillary Hyperhidrosis Drug Sales by Country/Region (2017-2022) & (K Pcs)
Table 32. Global Axillary Hyperhidrosis Drug Sales Market Share by Country/Region (2017-2022)
Table 33. Global Axillary Hyperhidrosis Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Axillary Hyperhidrosis Drug Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Axillary Hyperhidrosis Drug Sales by Country (2017-2022) & (K Pcs)
Table 36. Americas Axillary Hyperhidrosis Drug Sales Market Share by Country (2017-2022)
Table 37. Americas Axillary Hyperhidrosis Drug Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Axillary Hyperhidrosis Drug Revenue Market Share by Country (2017-2022)
Table 39. Americas Axillary Hyperhidrosis Drug Sales by Type (2017-2022) & (K Pcs)
Table 40. Americas Axillary Hyperhidrosis Drug Sales Market Share by Type (2017-2022)
Table 41. Americas Axillary Hyperhidrosis Drug Sales by Application (2017-2022) & (K Pcs)
Table 42. Americas Axillary Hyperhidrosis Drug Sales Market Share by Application (2017-2022)
Table 43. APAC Axillary Hyperhidrosis Drug Sales by Region (2017-2022) & (K Pcs)
Table 44. APAC Axillary Hyperhidrosis Drug Sales Market Share by Region (2017-2022)
Table 45. APAC Axillary Hyperhidrosis Drug Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Axillary Hyperhidrosis Drug Revenue Market Share by Region (2017-2022)
Table 47. APAC Axillary Hyperhidrosis Drug Sales by Type (2017-2022) & (K Pcs)
Table 48. APAC Axillary Hyperhidrosis Drug Sales Market Share by Type (2017-2022)
Table 49. APAC Axillary Hyperhidrosis Drug Sales by Application (2017-2022) & (K Pcs)
Table 50. APAC Axillary Hyperhidrosis Drug Sales Market Share by Application (2017-2022)
Table 51. Europe Axillary Hyperhidrosis Drug Sales by Country (2017-2022) & (K Pcs)
Table 52. Europe Axillary Hyperhidrosis Drug Sales Market Share by Country (2017-2022)
Table 53. Europe Axillary Hyperhidrosis Drug Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Axillary Hyperhidrosis Drug Revenue Market Share by Country (2017-2022)
Table 55. Europe Axillary Hyperhidrosis Drug Sales by Type (2017-2022) & (K Pcs)
Table 56. Europe Axillary Hyperhidrosis Drug Sales Market Share by Type (2017-2022)
Table 57. Europe Axillary Hyperhidrosis Drug Sales by Application (2017-2022) & (K Pcs)
Table 58. Europe Axillary Hyperhidrosis Drug Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Axillary Hyperhidrosis Drug Sales by Country (2017-2022) & (K Pcs)
Table 60. Middle East & Africa Axillary Hyperhidrosis Drug Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Axillary Hyperhidrosis Drug Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Axillary Hyperhidrosis Drug Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Axillary Hyperhidrosis Drug Sales by Type (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Axillary Hyperhidrosis Drug Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Axillary Hyperhidrosis Drug Sales by Application (2017-2022) & (K Pcs)
Table 66. Middle East & Africa Axillary Hyperhidrosis Drug Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Axillary Hyperhidrosis Drug
Table 68. Key Market Challenges & Risks of Axillary Hyperhidrosis Drug
Table 69. Key Industry Trends of Axillary Hyperhidrosis Drug
Table 70. Axillary Hyperhidrosis Drug Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Axillary Hyperhidrosis Drug Distributors List
Table 73. Axillary Hyperhidrosis Drug Customer List
Table 74. Global Axillary Hyperhidrosis Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 75. Global Axillary Hyperhidrosis Drug Sales Market Forecast by Region
Table 76. Global Axillary Hyperhidrosis Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Axillary Hyperhidrosis Drug Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Axillary Hyperhidrosis Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 79. Americas Axillary Hyperhidrosis Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Axillary Hyperhidrosis Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 81. APAC Axillary Hyperhidrosis Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Axillary Hyperhidrosis Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Europe Axillary Hyperhidrosis Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Axillary Hyperhidrosis Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Middle East & Africa Axillary Hyperhidrosis Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Axillary Hyperhidrosis Drug Sales Forecast by Type (2023-2028) & (K Pcs)
Table 87. Global Axillary Hyperhidrosis Drug Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Axillary Hyperhidrosis Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Axillary Hyperhidrosis Drug Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Axillary Hyperhidrosis Drug Sales Forecast by Application (2023-2028) & (K Pcs)
Table 91. Global Axillary Hyperhidrosis Drug Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Axillary Hyperhidrosis Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Axillary Hyperhidrosis Drug Revenue Market Share Forecast by Application (2023-2028)
Table 94. Allergan Plc Basic Information, Axillary Hyperhidrosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Allergan Plc Axillary Hyperhidrosis Drug Product Offered
Table 96. Allergan Plc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 97. Allergan Plc Main Business
Table 98. Allergan Plc Latest Developments
Table 99. Brickell Biotech Inc Basic Information, Axillary Hyperhidrosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Brickell Biotech Inc Axillary Hyperhidrosis Drug Product Offered
Table 101. Brickell Biotech Inc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 102. Brickell Biotech Inc Main Business
Table 103. Brickell Biotech Inc Latest Developments
Table 104. Dermira Inc Basic Information, Axillary Hyperhidrosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Dermira Inc Axillary Hyperhidrosis Drug Product Offered
Table 106. Dermira Inc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 107. Dermira Inc Main Business
Table 108. Dermira Inc Latest Developments
Table 109. Dr. August Wolff GmbH & Co KG Arzneimittle Basic Information, Axillary Hyperhidrosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Product Offered
Table 111. Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 112. Dr. August Wolff GmbH & Co KG Arzneimittle Main Business
Table 113. Dr. August Wolff GmbH & Co KG Arzneimittle Latest Developments
Table 114. GlaxoSmithKline Plc Basic Information, Axillary Hyperhidrosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Product Offered
Table 116. GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 117. GlaxoSmithKline Plc Main Business
Table 118. GlaxoSmithKline Plc Latest Developments
Table 119. TheraVida Inc Basic Information, Axillary Hyperhidrosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. TheraVida Inc Axillary Hyperhidrosis Drug Product Offered
Table 121. TheraVida Inc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 122. TheraVida Inc Main Business
Table 123. TheraVida Inc Latest Developments
LIST OF FIGURES
Figure 1. Picture of Axillary Hyperhidrosis Drug
Figure 2. Axillary Hyperhidrosis Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Axillary Hyperhidrosis Drug Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Axillary Hyperhidrosis Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Axillary Hyperhidrosis Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Botulinum ToxinA
Figure 10. Product Picture of Glycopyrrolate
Figure 11. Product Picture of Glycopyrronium Tosylate
Figure 12. Product Picture of Others
Figure 13. Global Axillary Hyperhidrosis Drug Sales Market Share by Type in 2021
Figure 14. Global Axillary Hyperhidrosis Drug Revenue Market Share by Type (2017-2022)
Figure 15. Axillary Hyperhidrosis Drug Consumed in Clinic
Figure 16. Global Axillary Hyperhidrosis Drug Market: Clinic (2017-2022) & (K Pcs)
Figure 17. Axillary Hyperhidrosis Drug Consumed in Hospital
Figure 18. Global Axillary Hyperhidrosis Drug Market: Hospital (2017-2022) & (K Pcs)
Figure 19. Axillary Hyperhidrosis Drug Consumed in Home Care
Figure 20. Global Axillary Hyperhidrosis Drug Market: Home Care (2017-2022) & (K Pcs)
Figure 21. Global Axillary Hyperhidrosis Drug Sales Market Share by Application (2017-2022)
Figure 22. Global Axillary Hyperhidrosis Drug Revenue Market Share by Application in 2021
Figure 23. Axillary Hyperhidrosis Drug Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Axillary Hyperhidrosis Drug Revenue Market Share by Company in 2021
Figure 25. Global Axillary Hyperhidrosis Drug Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Axillary Hyperhidrosis Drug Revenue Market Share by Geographic Region in 2021
Figure 27. Global Axillary Hyperhidrosis Drug Sales Market Share by Region (2017-2022)
Figure 28. Global Axillary Hyperhidrosis Drug Revenue Market Share by Country/Region in 2021
Figure 29. Americas Axillary Hyperhidrosis Drug Sales 2017-2022 (K Pcs)
Figure 30. Americas Axillary Hyperhidrosis Drug Revenue 2017-2022 ($ Millions)
Figure 31. APAC Axillary Hyperhidrosis Drug Sales 2017-2022 (K Pcs)
Figure 32. APAC Axillary Hyperhidrosis Drug Revenue 2017-2022 ($ Millions)
Figure 33. Europe Axillary Hyperhidrosis Drug Sales 2017-2022 (K Pcs)
Figure 34. Europe Axillary Hyperhidrosis Drug Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Axillary Hyperhidrosis Drug Sales 2017-2022 (K Pcs)
Figure 36. Middle East & Africa Axillary Hyperhidrosis Drug Revenue 2017-2022 ($ Millions)
Figure 37. Americas Axillary Hyperhidrosis Drug Sales Market Share by Country in 2021
Figure 38. Americas Axillary Hyperhidrosis Drug Revenue Market Share by Country in 2021
Figure 39. United States Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Axillary Hyperhidrosis Drug Sales Market Share by Region in 2021
Figure 44. APAC Axillary Hyperhidrosis Drug Revenue Market Share by Regions in 2021
Figure 45. China Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Axillary Hyperhidrosis Drug Sales Market Share by Country in 2021
Figure 52. Europe Axillary Hyperhidrosis Drug Revenue Market Share by Country in 2021
Figure 53. Germany Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Axillary Hyperhidrosis Drug Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Axillary Hyperhidrosis Drug Revenue Market Share by Country in 2021
Figure 60. Egypt Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Axillary Hyperhidrosis Drug in 2021
Figure 66. Manufacturing Process Analysis of Axillary Hyperhidrosis Drug
Figure 67. Industry Chain Structure of Axillary Hyperhidrosis Drug
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 1. Picture of Axillary Hyperhidrosis Drug
Figure 2. Axillary Hyperhidrosis Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Axillary Hyperhidrosis Drug Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Axillary Hyperhidrosis Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Axillary Hyperhidrosis Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Botulinum ToxinA
Figure 10. Product Picture of Glycopyrrolate
Figure 11. Product Picture of Glycopyrronium Tosylate
Figure 12. Product Picture of Others
Figure 13. Global Axillary Hyperhidrosis Drug Sales Market Share by Type in 2021
Figure 14. Global Axillary Hyperhidrosis Drug Revenue Market Share by Type (2017-2022)
Figure 15. Axillary Hyperhidrosis Drug Consumed in Clinic
Figure 16. Global Axillary Hyperhidrosis Drug Market: Clinic (2017-2022) & (K Pcs)
Figure 17. Axillary Hyperhidrosis Drug Consumed in Hospital
Figure 18. Global Axillary Hyperhidrosis Drug Market: Hospital (2017-2022) & (K Pcs)
Figure 19. Axillary Hyperhidrosis Drug Consumed in Home Care
Figure 20. Global Axillary Hyperhidrosis Drug Market: Home Care (2017-2022) & (K Pcs)
Figure 21. Global Axillary Hyperhidrosis Drug Sales Market Share by Application (2017-2022)
Figure 22. Global Axillary Hyperhidrosis Drug Revenue Market Share by Application in 2021
Figure 23. Axillary Hyperhidrosis Drug Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Axillary Hyperhidrosis Drug Revenue Market Share by Company in 2021
Figure 25. Global Axillary Hyperhidrosis Drug Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Axillary Hyperhidrosis Drug Revenue Market Share by Geographic Region in 2021
Figure 27. Global Axillary Hyperhidrosis Drug Sales Market Share by Region (2017-2022)
Figure 28. Global Axillary Hyperhidrosis Drug Revenue Market Share by Country/Region in 2021
Figure 29. Americas Axillary Hyperhidrosis Drug Sales 2017-2022 (K Pcs)
Figure 30. Americas Axillary Hyperhidrosis Drug Revenue 2017-2022 ($ Millions)
Figure 31. APAC Axillary Hyperhidrosis Drug Sales 2017-2022 (K Pcs)
Figure 32. APAC Axillary Hyperhidrosis Drug Revenue 2017-2022 ($ Millions)
Figure 33. Europe Axillary Hyperhidrosis Drug Sales 2017-2022 (K Pcs)
Figure 34. Europe Axillary Hyperhidrosis Drug Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Axillary Hyperhidrosis Drug Sales 2017-2022 (K Pcs)
Figure 36. Middle East & Africa Axillary Hyperhidrosis Drug Revenue 2017-2022 ($ Millions)
Figure 37. Americas Axillary Hyperhidrosis Drug Sales Market Share by Country in 2021
Figure 38. Americas Axillary Hyperhidrosis Drug Revenue Market Share by Country in 2021
Figure 39. United States Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Axillary Hyperhidrosis Drug Sales Market Share by Region in 2021
Figure 44. APAC Axillary Hyperhidrosis Drug Revenue Market Share by Regions in 2021
Figure 45. China Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Axillary Hyperhidrosis Drug Sales Market Share by Country in 2021
Figure 52. Europe Axillary Hyperhidrosis Drug Revenue Market Share by Country in 2021
Figure 53. Germany Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Axillary Hyperhidrosis Drug Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Axillary Hyperhidrosis Drug Revenue Market Share by Country in 2021
Figure 60. Egypt Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Axillary Hyperhidrosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Axillary Hyperhidrosis Drug in 2021
Figure 66. Manufacturing Process Analysis of Axillary Hyperhidrosis Drug
Figure 67. Industry Chain Structure of Axillary Hyperhidrosis Drug
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
